AGP Picks
View all

Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on August 10, 2026

Alvotech to Report Financial Results for H1 2026
Life Biosciences Appoints Stephen Webster to Board of Directors
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma
Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
Spyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results
Park Dental Partners, Inc. Announces Agreement to Acquire Village Family Dental Services Organization - Enters North Carolina Market
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
Replimune Announces Pricing of $150 Million Underwritten Offering
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
Entente Education Canada awards $105,000 in scholarships Investing in the students shaping Canada’s future
CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance
Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board
Kraig Biocraft Laboratories CEO Kim Thompson Publishes Thought Leadership Article on the Next Chapter of Authored Biology in Biocompare
Oruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical Endpoints, and Reports Second Quarter 2026 Financial Results

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Idaho Healthcare Hub

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.